Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis

G Reshmi1, Charles Sona, M Radhakrishna Pillai

  • 1Integrated Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India.

Insights

This review reveals complex regulatory patterns between microRNAs and transcription factors in cancer metastasis. Understanding these interactions, like the ZEB1 and miR-200 feedback loop, is key for new cancer therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Bioinformatics

Background:

  • Metastasis significantly impacts cancer patient outcomes, yet its regulatory mechanisms, particularly microRNA involvement, are not fully understood.
  • Identifying upstream regulators of metastasis is crucial for improving cancer therapeutics.

Purpose of the Study:

  • To computationally analyze coordinated gene regulation by microRNAs and transcription factors in metastasis.
  • To elucidate novel regulatory patterns and information flow in cancer metastasis.

Main Methods:

  • Computational analysis of gene regulatory networks.
  • Examination of di-directional regulation between microRNAs and transcription factors.
  • Focus on regulatory patterns specific to the metastatic process.

Main Results:

  • Discovery of unexpected regulatory patterns between microRNAs and transcription factors.
  • Identification of a double positive feedback loop involving ZEB1 and miR-200 during epithelial-mesenchymal transition.
  • Elucidation of information flow and adaptable controls involving microRNAs and transcription factors.

Conclusions:

  • The study provides a regulatory framework for understanding post-transcriptional gene regulation in cancer metastasis.
  • Findings offer insights into microRNA and transcription factor coordination, aiding future experimental research.
  • Understanding these intricate networks can lead to novel therapeutic strategies for cancer metastasis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...